Guidance for Endocyte, Inc. (ECYT)

Period	Range	Estimate	Revenue Range	Revenue Estimate	Target	Details
Q4 2017	N/A	N/A	N/A	N/A	= Maintained	Details
Q3 2017	N/A	N/A	N/A	N/A	= Maintained	Details
Q2 2017	N/A	N/A	N/A	N/A	= Maintained	Details
Q1 2017	N/A	N/A	N/A	N/A	= Maintained	Details

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)